Other compounds, as fucoidan and sulfated galactofucan have been shown to reduce tumor growth and inhibit tumor angiogenesis, in part through the inhibition of STAT3-regulated genes, as VEGF, Bcl-xL, and cyclin D1 [169,170]. The gene discussed is BCL2L1; the disease is neoplasm.